A PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism.

TitleA PH domain within OCRL bridges clathrin-mediated membrane trafficking to phosphoinositide metabolism.
Publication TypeJournal Article
Year of Publication2009
AuthorsMao Y, Balkin DM, Zoncu R, Erdmann KS, Tomasini L, Hu F, Jin MM, Hodsdon ME, De Camilli P
JournalEMBO J
Volume28
Issue13
Pagination1831-42
Date Published2009 Jul 08
ISSN1460-2075
KeywordsAmino Acid Sequence, Animals, Binding Sites, Clathrin, Coated Vesicles, Endocytosis, HeLa Cells, Humans, Models, Molecular, Molecular Sequence Data, Mutation, Nuclear Magnetic Resonance, Biomolecular, Phosphatidylinositols, Phospholipids, Phosphoric Monoester Hydrolases, Protein Conformation, Protein Structure, Tertiary, Rats, Sequence Alignment
Abstract

OCRL, whose mutations are responsible for Lowe syndrome and Dent disease, and INPP5B are two similar proteins comprising a central inositol 5-phosphatase domain followed by an ASH and a RhoGAP-like domain. Their divergent NH2-terminal portions remain uncharacterized. We show that the NH2-terminal region of OCRL, but not of INPP5B, binds clathrin heavy chain. OCRL, which in contrast to INPP5B visits late stage endocytic clathrin-coated pits, was earlier shown to contain another binding site for clathrin in its COOH-terminal region. NMR structure determination further reveals that despite their primary sequence dissimilarity, the NH2-terminal portions of both OCRL and INPP5B contain a PH domain. The novel clathrin-binding site in OCRL maps to an unusual clathrin-box motif located in a loop of the PH domain, whose mutations reduce recruitment efficiency of OCRL to coated pits. These findings suggest an evolutionary pressure for a specialized function of OCRL in bridging phosphoinositide metabolism to clathrin-dependent membrane trafficking.

DOI10.1038/emboj.2009.155
Alternate JournalEMBO J
PubMed ID19536138
PubMed Central IDPMC2711190
Grant List5T32GM07205 / GM / NIGMS NIH HHS / United States
P01 CA046128 / CA / NCI NIH HHS / United States
/ HHMI / Howard Hughes Medical Institute / United States
P30 DA018343 / DA / NIDA NIH HHS / United States
CA46128 / CA / NCI NIH HHS / United States
DA018343 / DA / NIDA NIH HHS / United States
CA 108992 / CA / NCI NIH HHS / United States
NS36251 / NS / NINDS NIH HHS / United States
R37 NS036251 / NS / NINDS NIH HHS / United States
1 S10 RR19895 / RR / NCRR NIH HHS / United States
S10 RR019895 / RR / NCRR NIH HHS / United States
DK45735 / DK / NIDDK NIH HHS / United States
R01 CA108992 / CA / NCI NIH HHS / United States
P30 DK045735 / DK / NIDDK NIH HHS / United States
R01 NS036251 / NS / NINDS NIH HHS / United States
T32 GM007205 / GM / NIGMS NIH HHS / United States
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065